Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Grows By 64.3%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 4,409 shares, an increase of 64.3% from the June 30th total of 2,684 shares. Based on an average daily trading volume, of 5,551 shares, the short-interest ratio is currently 0.8 days.

Cardio Diagnostics Stock Performance

CDIOW stock opened at $0.01 on Friday. The firm has a 50 day moving average of $0.02 and a 200-day moving average of $0.02. Cardio Diagnostics has a 12 month low of $0.01 and a 12 month high of $0.07.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.